The DOI matches its Crossref record.
Transforming genes of human hematopoietic tumors: frequent detection of ras-related oncogenes whose activation appears to be independent of tumor phenotype.
Open accessAbstract
We surveyed 22 human hematopoietic tumors and tumor cell lines for sequences capable of transforming NIH 3T3 cells by DNA transfection. A primary human acute myelogenous leukemia, a chronic myelogenous leukemia cell line, and cell lines derived from three independent acute lymphocytic leukemias demonstrated oncogenes capable of conferring the transformed phenotype to NIH 3T3 cells through serial cycles of transfection. One of three transforming genes associated with acute lymphocytic leukemia cells (classified as thymocyte developmental stage II) was identified as the activated cellular homologue of the Kirsten murine sarcoma virus onc gene, kis, a member of the ras family of onc genes. A transforming gene, which was demonstrated to be common to several human myeloid and lymphoid tumor cells, was shown to be a distantly related member of the ras gene family. Thus, the NIH 3T3 transfection assay commonly detects related oncogenes in human hematopoietic tumor cells. Moreover, the activation of these oncogenes appears to be independent of the specific stage of cell differentiation or tumor phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The ras gene family and human carcinogenesis
Bos, J. L. (1988) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(88)90004-8 · Cited by 782
THE MOLECULAR GENETICS OF CELLULAR ONCOGENES
Varmus, H. E. (1984) · Annual Review of Genetics · doi:10.1146/annurev.ge.18.120184.003005 · Cited by 756
Sukumar, S., Notario, V., Martin-Zanca, D., & Barbacid, M. (1983) · Nature · doi:10.1038/306658a0 · Cited by 706
Biological properties of human c-Ha-ras1 genes mutated at codon 12
Seeburg, P. H., Colby, W. W., Capon, D. J., Goeddel, D. V., & Levinson, A. D. (1984) · Nature · doi:10.1038/312071a0 · Cited by 585
Santos, E., Martin-Zanca, D., Reddy, E. P., Pierotti, M. A., Della Porta, G., & Barbacid, M. (1984) · Science · doi:10.1126/science.6695174 · Cited by 418
Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia
Bos, J. L., Toksoz, D., Marshall, C. J., Verlaan-de Vries, M., Veeneman, G. H., van der Eb, A. J., van Boom, J. H., Janssen, J. W. G., & Steenvoorden, A. C. M. (1985) · Nature · doi:10.1038/315726a0 · Cited by 365
Farr, C. J., Saiki, R. K., Erlich, H. A., McCormick, F., & Marshall, C. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1629 · Cited by 356
A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides
Verlaan-de Vries, M., Bogaard, M. E., van den Elst, H., van Boom, J. H., van der Eb, A. J., & Bos, J. L. (1986) · Gene · doi:10.1016/0378-1119(86)90335-5 · Cited by 336
Krontiris, T. G., DiMartino, N. A., Colb, M., & Parkinson, D. R. (1985) · Nature · doi:10.1038/313369a0 · Cited by 280
Konopka, J. B., Watanabe, S. M., Singer, J. W., Collins, S. J., & Witte, O. N. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.6.1810 · Cited by 156
Chromosomal localization of three humanras genes by in situ molecular hybridization
Popescu, N. C., Amsbaugh, S. C., DiPaolo, J. A., Tronick, S. R., Aaronson, S. A., & Swan, D. C. (1985) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01534703 · Cited by 81
Self-citationChow, V. T. K., Quek, H. H., & Tock, E. P. C. (1993) · Cancer Letters · doi:10.1016/0304-3835(93)90256-9 · Cited by 59
Metadata
- Authors
- Eva, A., Tronick, S. R., Gol, R. A., Pierce, J. H., & Aaronson, S. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1983-08
- Volume
- 80
- Issue
- 16
- Pages
- 4926-4930
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2012432612
- Cited by
- 168
- References
- 0
- FWCI
- 13.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.